Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Psychiatry
•
Primary Care
•
Geriatric Medicine
•
geriatric psyc
How would you recommend cross-titrating from paroxetine to another SSRI with less anticholinergic burden in an older adult?
Any pearls or tips re: how to design a taper strategy and when to start the alternative agent?
Related Questions
What is your approach to deprescribing gabapentinoids so as to prevent withdrawal effects?
How do you decide when to initiate medical workup (e.g., thyroid, B12, infection) in a geriatric patient experiencing new onset or worsening low mood?
What is your approach to initiation of mirtazapine for appetite stimulation and depression in older adults, both in terms of starting dose and titration?
In older adults with chronic mild hyponatremia (Na 128–132) attributed to SSRIs but good psychiatric response, do you tolerate persistent hyponatremia, reduce the dose, or switch agents?
Would you consider transitioning patients older than 75 years of age with coronary disease from statins and/or other lipid-lowering agents to PCSK9 inhibitors given concerns for polypharmacy, provided their LDL levels remain at or below goal?
In older adults with mild cognitive impairment, do you ever prescribe cholinesterase inhibitors and/or memantine?
Do you recommend for/against use of AI chatbot companions to improve quality of life for older adults with cognitive impairment?
How do you approach deprescribing psychiatric medications in elderly patients with polypharmacy concerns?
How would you approach incorporating wearable technology in your assessment of frailty of older patients?
How would you approach counseling an older patient with significant hearing loss and nonadherence to use of hearing aids?